Irland - engelsk - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - linezolid (form iii) - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid

Storbritannien - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

genus pharmaceuticals ltd - linezolid - oral tablet - 600mg

Storbritannien - engelsk - myHealthbox

actavis group ptc ehf - linezolid - film-coated tablets - 600mg - other antibacterials - nosocomial pneumonia community acquired pneumonia linezolid is indicated for the treatment of community acquired pneumonia and nosocomial pneumonia when known or suspected to be caused by susceptible gram positive bacteria. in determining whether linezolid is an appropriate treatment, the results of microbiological tests or information on the prevalence of resistance to antibacterial agents among gram positive bacteria should be taken into consideration. (see section 5.1 for the appropriate organisms). linezolid is not active against infections caused by gram negative pathogens. specific therapy against gram negative organisms must be initiated concomitantly if a gram negative pathogen is documented or suspected.

Irland - engelsk - HPRA (Health Products Regulatory Authority)

wockhardt uk limited - linezolid - film-coated tablet - 600 milligram(s) - other antibacterials; linezolid

Irland - engelsk - HPRA (Health Products Regulatory Authority)

pfizer healthcare ireland - linezolid - solution for infusion - 2 milligram(s)/millilitre - other antibacterials; linezolid

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

mayne pharma international pty ltd - linezolid -

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - linezolid, quantity: 600 mg - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; microcrystalline cellulose; magnesium stearate; purified talc; poloxamer; colloidal anhydrous silica; sodium starch glycollate type a; propylene glycol; brilliant blue fcf; ethanol; purified water; shellac; strong ammonia solution; titanium dioxide; hypromellose; macrogol 400 - linezolid is indicated for the treatment of suspected or proven infections due to gram positive organisms resistant to multiple classes of antibiotics, including methicillin resistant staphylococcus species and vancomycin resistant enterococcus species. ,linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected

Canada - engelsk - Health Canada

sandoz canada incorporated - linezolid - solution - 2mg - linezolid 2mg - oxazolidinones

USA - engelsk - NLM (National Library of Medicine)

american health packaging - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 600 mg

USA - engelsk - NLM (National Library of Medicine)

teva parenteral medicines, inc. - linezolid (unii: isq9i6j12j) (linezolid - unii:isq9i6j12j) - linezolid 2 mg in 1 ml